Public ID: PID-G2NXY9

Lack of health technology assessment (HTA) framework for monitoring and valuation of drugs in Brazil

in Brazil

Trade barrier summary

Brazil's HTA process, led by the National Committee for Health Technology Incorporation (Conitec), lacks a clear framework to monitor and valuate drugs after they are incorporated into the national healthcare system. This limits Brazil's ability to establish risk-sharing agreements and hinders the incorporation of innovative drugs, especially in oncology. Establishing this framework will enable UK pharmaceutical companies to expand their portfolio.

---

Sectors affected

• Pharmaceuticals and biotechnology
• Healthcare services

---

Resolved

No

---

Date reported

15 February 2024

---

Last updated

5 January 2026

---

Public ID

PID-G2NXY9

---

If a trade barrier is affecting your exports or investment from the UK, please let us know on report a trade barrier .

If you export goods you can check duties and customs procedures for your chosen market.